RELMADA THERAPEUTICS CLOSES $3.0 MILLION SERIES A FINANCING AND COMPLETES THE IN-LICENSING OF d-METHADONE FROM MEDEOR INC.
RELMADA THERAPEUTICS ANNOUNCES LEVOCAP ER DEVELOPMENT PROGRESS PRWeb – Monday March 4, 2013
